About SWL Therapeutics
About Us
SWL Therapeutics was founded to translate early scientific discoveries in kidney, heart, and metabolic health into practical therapeutic programs.
Our Story
Academic Roots: Our technology platforms are rooted in NIH-supported research spanning transplantation, metabolic disease, immune dysfunction, bioengineering, and precision therapeutics, providing the scientific foundation for our next-generation therapeutic pipeline.
Early Translation: We bridge scientific discovery and clinical application through mechanism-driven research, therapeutic development, and rigorous preclinical validation.
Patient-Centered Innovation: Our mission is to develop innovative therapeutics that improve the lives of patients with transplantation, metabolic, and immune-mediated diseases..
Our Mission
To transform promising academic discoveries into rigorously developed biomedical technologies that address kidney, heart, and metabolic disease.
Our Vision
To become a trusted translational therapeutics company that bridges university science and patient-centered innovation, advancing new approaches for organ protection, functional recovery, and metabolic health.
Academic Roots
Our programs originate from NIH-supported research and deep expertise in renal and transplant biology.
Early Translation
We focus on Phase I-ready questions: feasibility, mechanism, reproducibility, and development potential.
Patient Direction
Our long-term goal is to create technologies that may improve outcomes in organ health and metabolic disease.